Mesirow Financial Investment Management, Inc. Sutro Biopharma, Inc. Transaction History

Mesirow Financial Investment Management, Inc.

$4.94 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$18.03 - $23.82 $19,003 - $25,106	-1,054 Closed	0 $0
Q1 2021 Apr 14, 2021	BUY	$20.29 - $27.54 $9,150 - $12,420	451 Added 74.79%	1,054 $24,000
Q4 2020 Jan 14, 2021	BUY	$10.16 - $23.98 $6,126 - $14,459	603 New	603 $13,000

Others Institutions Holding STRO

# of Institutions

137

Shares Held

62.4M

Call Options Held

77.1K

Put Options Held

31.4K

Suvretta Capital Management, LLC New York, NY

7.19M
Shares

$13.5 Million
0.98% of portfolio
Black Rock Inc. New York, NY

6.91M
Shares

$13 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.2M
Shares

$7.89 Million
0.0% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

3M
Shares

$5.64 Million
0.03% of portfolio
Bio Impact Capital LLC Cambridge, MA

2.83M
Shares

$5.32 Million
1.53% of portfolio

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $98.1M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.

Account